Upadacitinib for refractory cutaneous disease in a patient with tif1γ-positive dermatomyositis. // Anais Brasileiros de Dermatologia. – URL: https://www.sciencedirect.com/science/article/pii/S036505962600156X?dgcid=rss_sd_all
Upadacitinib for refractory cutaneous disease in a patient with tif1γ-positive dermatomyositis. Anais Brasileiros de Dermatologia. https://www.sciencedirect.com/science/article/pii/S036505962600156X?dgcid=rss_sd_all
“Upadacitinib for refractory cutaneous disease in a patient with tif1γ-positive dermatomyositis.” Anais Brasileiros de Dermatologia.
@article{article35251,
title = {Upadacitinib for refractory cutaneous disease in a patient with tif1γ-positive dermatomyositis},
journal = {Anais Brasileiros de Dermatologia},
url = {https://www.sciencedirect.com/science/article/pii/S036505962600156X?dgcid=rss_sd_all}
}